McMaster University

McMaster University

Elizabeth McCready,


Associate Professor
Pathology and Molecular Medicine

Division: Clinical Pathology
Specialty: Genetics

Head of Molecular Cytogenetics

Program Director, Canadian College of Medical Geneticists (CCMG) Training Program (program website)

M cMaster University
3N20 Health Sciences Centre
905-521-2100 ext 73706

dr mccready photo

Faculty Biography

Education and Professional Standing

  • Fellow of the Canadian  College of Medical Geneticists (FCCMG), 2008.  Fellowship training program in Cytogenetics, University of Ottawa, 2007-2008
  • Fellow of the Canadian College of Medical Geneticists (FCCMG), 2006.  Fellowship training program in Molecular Cytogenetics, University of Ottawa, 2004-2006
  • PhD, Human Genetics, University of Ottawa, 2004
  • MSc, Faculty of Dentistry, University of Toronto, 1999
  • BSc, Molecular Biology and Biotechnology, McMaster University, 1996


Research Focus

Dr. McCready’s research interests include  the molecular and cytogenetic characterization of hereditary diseases.  Current research activities are largely translational in nature and are focused on rare genetic variants and novel loci that may contribute to developmental and neuropsychiatric disorders.  She is also interested in the development and implementation of molecular cytogenomic technologies into clinical laboratory practice.

Clinical Focus

Dr. McCready is a member of the Laboratory Genetic Services Division within the Hamilton Regional Laboratory Medicine Program.  She is head of the Molecular Cytogenetic Laboratory, which provides clinical testing for a range of chromosomal disorders using both molecular cytogenomic and historical cytogenetic approaches.

Academic Interests

Dr. McCready is primarily involved in teaching residents and fellows through the Postgraduate Pathology and Molecular Pathology Program but also teaches occasionally in other postgraduate and undergraduate programs within the Faculty of Health Sciences.  She also coordinates Genetic Education Rounds locally and  is a member of Training and Credentialling committees at the national level (Canadian College of Medical Geneticists).

Selected Publications

Honeywell C, Douglas S, Blumenthal AL, Allanson J, McGowan-Jordan J, McCready ME. Apparent transmission distortion of a pericentric chromosome one inversion in a large multi-generation pedigree.  American Journal of Medical Genetics. 158A(6):1262-8. 2012.

Argiropoulos B, Clifford B, Crocker S, Sinclair-Bourque E, McCready ME, McGowan-Jordan J, Johnston DL, Padmore R.  HLA-DRnegative, CD34negative Hypergranular Acute Myeloid Leukemia with Trisomy 6 and del(5)(q22q33): A Case Report and Literature Review. Journal of Pediatric Hematology/Oncology. 33(7):e289-295. 2011.

McCready ME, Carson NL, Chakraborty P, Clarke JTR, Callahan JW, Skomoroski MA, Chan AKJ, Bamforth F, Casey R,Rupar CA,Geraghty MT. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II. Molecular Genetics and Metabolism, 92(4):325-335. 2007.

McCready ME*, Grimsey A*, Styer T, Nikkel S, Bulman DE. A century later Farabee has his mutation. Human Genetics, 117:285-287. 2005. (* co-first authors)

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0